ADGI

Adagio Therapeutics Stock Price

44.92
0.00 (0.0%)
44.92

Low
20.50

52 Week Range

High
59.50

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Adagio Therapeutics Inc ADGI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 44.92 07:00:01
Open Price Low Price High Price Close Price Prev Close
44.92
Bid Price Ask Price Spread News
44.92 48.00 3.08 - -
Trades Volume Avg Volume 52 Week Range
1 22 - 20.50 - 59.50
Last Trade Time Type Quantity Stock Price Currency
05:40:01 22 $ 44.92 USD

Period:

Draw Mode:

Adagio Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 5.00B 111.25M 64.02M $ - $ - -1.25 -25.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 68.77M 1.90%

more financials information »

Adagio Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADGI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week55.0159.5043.5250.601,136,297-10.09-18.34%
1 Month28.2059.5026.6846.21699,04916.7259.29%
3 Months21.0059.5020.5037.22729,34923.92113.9%
6 Months21.0059.5020.5037.22729,34923.92113.9%
1 Year21.0059.5020.5037.22729,34923.92113.9%
3 Years21.0059.5020.5037.22729,34923.92113.9%
5 Years21.0059.5020.5037.22729,34923.92113.9%

Adagio Therapeutics Description

Adagio Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease 2019, or COVID-19, the disease caused by the virus SARS-CoV-2 and its variants.
Your Recent History
NASDAQ
ADGI
Adagio The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210923 12:19:55